Science

Ravi Parikh: Predicting immunotherapy response in non-small cell lung cancer

Ravi Parikh/chibe.upenn.edu

Dec 20, 2024, 14:19

Ravi Parikh: Predicting immunotherapy response in non-small cell lung cancer

Ravi Parikh, Director of Human-Algorithm Collaboration Lab at Winship Cancer Institute of Emory University, shared a post on X about a recent paper by him and colleagues published in JCO Clinical Cancer Informatics:

“Check out our JCO Clinical Cancer Informatics paper on the development and real-world/clinical trial validation of Deep Learning CT biomarker to predict immunotherapy response in non-small cell lung cancer! Presented at ASCO24.”

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer

Authors: Chiharu Sako et al.

More posts featuring Ravi Parikh.

ASCO24 cancer Chiharu Sako Chong Duan George Simon Hugo Aerts JCO Clinical Cancer Informatics Kevin Maresca non small cell lung cancer NSCLC OncoDaily Oncology Petr Jordan Ravi Parikh Sean Kent Taly Gilat Schmidt

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage